Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2044-5385
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma ; volume:10 ; number:12 ; day:14 ; month:12 ; year:2020 ; pages:1-10 ; date:12.2020
Blood cancer journal ; 10, Heft 12 (14.12.2020), 1-10, 12.2020
- Creator
-
Gu, Yanyan
Barwick, Benjamin G.
Shanmugam, Mala
Hofmeister, Craig C.
Kaufman, Jonathan
Nooka, Ajay
Gupta, Vikas
Dhodapkar, Madhav
Boise, Lawrence H.
Lonial, Sagar
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41408-020-00393-0
- URN
-
urn:nbn:de:101:1-2021012118452021473132
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gu, Yanyan
- Barwick, Benjamin G.
- Shanmugam, Mala
- Hofmeister, Craig C.
- Kaufman, Jonathan
- Nooka, Ajay
- Gupta, Vikas
- Dhodapkar, Madhav
- Boise, Lawrence H.
- Lonial, Sagar
- SpringerLink (Online service)
Other Objects (12)
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Ancistrocladinium A induces apoptosis in proteasome inhibitor-resistant multiple myeloma cells: a promising therapeutic agent candidate
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma
UVB-mediated down-regulation of proteasome in cultured human primary pterygium fibroblasts
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
Proteasome assembly and its regulation
Characterization of proteasome precursor complexes
Ubiquitin proteasome system and myopathies
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Ancistrocladinium A induces apoptosis in proteasome inhibitor-resistant multiple myeloma cells: a promising therapeutic agent candidate
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma
UVB-mediated down-regulation of proteasome in cultured human primary pterygium fibroblasts
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
Proteasome assembly and its regulation
Characterization of proteasome precursor complexes
Ubiquitin proteasome system and myopathies
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Ancistrocladinium A induces apoptosis in proteasome inhibitor-resistant multiple myeloma cells: a promising therapeutic agent candidate
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma
UVB-mediated down-regulation of proteasome in cultured human primary pterygium fibroblasts
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
Proteasome assembly and its regulation
Characterization of proteasome precursor complexes